An inexpensive, fast and sensitive quantitative lateral flow magneto-immunoassay for total prostate specific antigen

Biosensors

Volumn 4, Issue 3, 2014, Pages 204-220

  Barnett, Jacqueline M ^a   Wraith, Patrick ^a   Kiely, Janice ^a   Persad, Raj ^b   Hurley, Katrina ^c   Hawkins, Peter ^a   Luxton, Richard ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Paramagnetic particles; Prostate specific antigen; Resonant coil magnetometer

Indexed keywords

ANTIGENS; BODY FLUIDS; IMMUNOLOGY; MAGNETOS; PARAMAGNETISM; UROLOGY;

DETECTION CHARACTERISTICS; IMMUNOCHROMATOGRAPHIC; LATERAL FLOW; LATERAL-FLOW ASSAYS; LATERAL-FLOW FORMATS; MULTIPLE ANALYTES; PARAMAGNETIC PARTICLES; PROSTATE SPECIFIC ANTIGEN; RESONANT COIL MAGNETOMETER; SERUM SAMPLES;

MAGNETOMETERS;

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LATERAL FLOW MAGNETO IMMUNOASSAY; LIMIT OF DETECTION; MAGNETOMETER; MALE; PILOT STUDY; POINT OF CARE TESTING; REPRODUCIBILITY;

EID: 84906088896     PISSN: None     EISSN: 20796374     Source Type: Journal    
DOI: 10.3390/bios4030204     Document Type: Article

References (39)

1. Hawkanes, B.I.; Kvam, C. Application of magnetic beads in bioassays. Nat. Biotech. 1993, 11, 60-63.
2. Hu, J.; Wang, S.; Wang, L.; Li, F.; Pingguan-Murphy, B.; Lu, T.J.; Feng, X. Advances in paper-based point-of-care diagnostics. Biosens. Bioeletron. 2014, 54, 585-597.
3. Gubala, V.; Harris, L.F.; Ricco, A.J.; Tan, M.X.; Williams, D.E. Point of Care Diagnostics: Status and future. Anal. Chem. 2012, 84, 487-515.
4. LaBorde, R.T.; O'Farrell, B. Paramagnetic particle detection in lateral-flow assays. IVD Technol. 2002, 8, 36-41.
5. Ibraimi, F.; Kriz, D.; Lu, M.; Hansson, L.O.; Kriz, K. Rapid one-step whole blood C-reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation. Anal. Bioanal. Chem. 2006, 384, 651-657.
6. Meyera, M.H.F.; Hartmanna, M.; Krauseb, H.J.; Blankensteinc, G.; Mueller-Chorusc, B.; Osterd, J.; Miethee, P.; Keusgen, M. CRP determination based on a novel magnetic biosensor. Biosens. Bioelectron. 2007, 22, 973-979.
7. Dittmer, W.U.; de Kievit, P.; Prins, M.W.J.; Vissers, J.L.M.; Mersch, M.E.C.; Martens, M.F.W.C. Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuation. J. Immunol. Meth. 2008, 338, 40-46.
8. Motte, L.; Benyettou, F.; de Beaucorps, C.; Lecouvey, M.; Milesovica, I.; Lalatonne, Y. Multimodal superparamagnetic nanoplatform for clinical applications: Immunoassays, imaging & therapy. Faraday Discuss. 2011, 149, 211-225.
9. Halla, D.A.; Gasterb, R.S.; Lina, T.; Osterfeldd, S.J.; Hane, S.; Murmanna, B.; Wang, S.X. GMR biosensor arrays: A system perspective. Biosens. Bioelectron. 2010, 25, 2051-2057.
10. Tamanaha, C.R.; Mulvaney, S.P.; Rife, J.C.; Whitman, L.J. Magnetic labelling, detection, and system integration. Biosens. Bioelectron. 2008, 24, 1-13.
11. Hawkins, P.; Luxton, R. Magnetic Nanoparticles in Immunoassays. In Magnetic Nanoparticles: From Fabrication to Clinical Applications, 1st ed.; Thanh, N.T.K., Ed.; CRC Press: London, UK, 2012; pp. 243-276.
12. Wang, S.X.; Li, G. Advances in giant magnetoresistance biosensors with magnetic nanoparticle tags: Review and outlook. IEEE Trans. Magn. 2008, 44, 1687-1702.
13. Popovic, R.S. Hall Effect Devices: Magnetic Sensors and Characterization of Semiconductors; Taylor & Francis: London, UK, 1991.
14. Eveness, J.; Kiely, J.; Hawkins, P.; Wraith, P.; Luxton, R. Evaluation of paramagnetic particles for use in a resonant coil magnetometer based magneto-immunoassay. Sens. Actuator. B Chem. 2009, 139, 538-542.
15. Nash, A.F.; Melezinek, I. The role of prostate specific antigen measurement in the detection and management of prostate cancer. Endocr. Relat. Canc. 2000, 7, 37-51.
16. Kiely, J.; Hawkins, P.; Wraith, P.; Luxton, R. Paramagnetic particle detection for use with an immunoassay based biosensor. IET Sci. Meas. Technol. 2007, 1, 270-275.
17. Richardson, J.; Hill, A.; Luxton, R.; Hawkins, P. A novel measuring system for the determination of paramagnetic particle labels for use in magneto-immunoassays. Biosens. Bioelectron. 2001, 16, 1127-1132.
18. Luxton, R.; Badesha, J.; Kiely, J.; Hawkins, P. Use of external magnetic fields to reduce reaction times in an immunoassay using micrometer-sized paramagnetic particles as labels (magnetoimmunoassay). Anal. Chem. 2004, 76, 1715-1719.
19. Ryu, Y.; Jin, Z.; Kang, M.S.; Kim, H.S. Increase in the detection sensitivity of a lateral flow assay for a cardiac marker by orientated immobilization of antibody. Biochip J. 2011, 5, 193-198.
20. Smith, P.K.; Krohn, R.I.; Hermanson, G.T.; Mallia, A.K.; Gartner, F.H.; Provenzano, M.D.; Fujimoto, E.K.; Goeke, N.M.; Olsen, B.J.; Klenk, D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150, 76-85.
21. Ahn, J.S.; Choi, S.; Jang, S.H.; Chang, H.J.; Kim, J.H.; Nahm, K.B.; Oh, S.W.; Choi, E.Y. Development of a point-of-care assay system for high-sensitivity C-reactive protein in whole blood. Clin. Chim. Acta 2003, 332, 51-59.
22. Altman, D.G. Practical Statistics for Medical Research; Chapman & Hall: London, UK, 1991.
23. Cohen, J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960, 20, 37-46.
24. Altman, D.G.; Bland, J.M. Diagnostic tests 1: Sensitivity and specificity. BMJ 1994, 308, doi:10.1136/bmj.308.6943.1552.
25. Altman, D.G.; Bland, J.M. Diagnostic tests 2: Predictive values. BMJ 1994, 309, doi:10.1136/ bmj.309.6947.102.
26. Sharif, E.; Kiely, J.; Luxton, R. Novel immunoassay technique for rapid measurement of intracellular proteins using paramagnetic particles. J. Immunol. Methods 2013, 388, 78-85.
27. D'Amico, A.V.; Chen, M.H.; Roehl, K.A.; Catalona, W.J. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N. Engl. J. Med. 2004, 351, 125-135.
28. Prostate Cancer: More Choices in PSA Tests. Available online: http://www.healthcare.siemens.co. uk/clinical-specialities/oncology/laboratory-diagnostics-in-oncology/prostate-cancer/laboratorians (accessed on 23 June 2014).
29. Lee, L.G.; Nordman, E.S.; Johnson, M.D.; Oldham, M.F. A low-cost, high-performance system for fluorescence lateral flow assays. Biosensors 2013, 3, 360-373.
30. Laitinen, M.P.; Vuento, M. Affinity immunosensor for milk progesterone: Identification of critical parameters. Biosens. Bioelectron. 1996, 11, 1207-1214.
31. O'Farrell, F.; Bauer, J. Developing Highly Sensitive, More Reproducible Lateral-Flow Assays. Part 1: New Approaches to Old Problems. IVD Technology, 2006; pp. 41-50. Available online: http://www.ivdtechnology.com/article/highly-sensitive (accessed on 8 April 2014).
32. Virekunnas, L. Colloidal Gold and Paramagnetic Labels in Lateral Flow Assay Detecting Ricin. M.S. Thesis. Tampere University of Technology, Tampere, Finland, 2012. Available online: https://dspace.cc.tut.fi/dpub/bitstream/handle/123456789/21191/Virekunnas.pdf?sequence=1, 240314 (accessed on 8 April 2014).
33. Richardson, J.; Hawkins, P.; Luxton, R. The use of coated paramagnetic particles as a physical label in a magneto-immunoassay. Biosens. Bioelectron. 2001, 16, 989-993.
34. Kort, F.; Martens, F.; Vanpoucke, H.; van Duijnhoven, H.L.; Blankenstein, M.A. Comparison of 6 automated assays for total and free prostate specific antigen with special reference to their reactivity towards the 96/670 reference preparation. Clin. Chem. 2006, 52, 1568-1574.
35. Tate, J.; Ward, G. Interferences in immunoassay. Clin. Biochem. Rev. 2004, 25, 105-120.
36. Fernandez-Sanchez, C.; McNeil, C.J.; Rawson, K.; Nilsson, O.; Leung, H.Y.; Gnanapragasam, V. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum. J. Immunol. Meth. 2005, 307, 1-12.
37. Catalona, W.J.; Partin, A.W.; Slawin, K.M. Use of percentage free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. JAMA 1998, 279, 1542-1547.
38. Diamandis, E.P.; Yousef, G.M. Human tissue kallikreins a family of new cancer biomarkers. Clin. Chem. 2002, 48, 1198-1205.
39. Madu, C.O.; Lu, Y. Novel diagnostic biomarkers for prostate cancer. J. Cancer 2010, 1, 150-177.